AAAAAA

   
Results: 1-10 |
Results: 10
BIOTRANSFORMATION OF CL-937 IN PRIMARY CULTURES OF RAT HEPATOCYTES - FORMATION OF GLUTATHIONE CONJUGATES
Authors: RENNER U BLANZ J FREUND S WAIDELICH D EHNINGER G ZELLER KP
Citation: U. Renner et al., BIOTRANSFORMATION OF CL-937 IN PRIMARY CULTURES OF RAT HEPATOCYTES - FORMATION OF GLUTATHIONE CONJUGATES, Drug metabolism and disposition, 23(1), 1995, pp. 94-101
JOINT DETECTION WITH COHERENT RECEIVER ANTENNA DIVERSITY IN CDMA MOBILE RADIO SYSTEMS
Authors: JUNG P BLANZ J
Citation: P. Jung et J. Blanz, JOINT DETECTION WITH COHERENT RECEIVER ANTENNA DIVERSITY IN CDMA MOBILE RADIO SYSTEMS, IEEE transactions on vehicular technology, 44(1), 1995, pp. 76-88
USE OF A WATER-SOLUBLE BUSULFAN FORMULATION - PHARMACOKINETIC STUDIESIN A CANINE MODEL
Authors: EHNINGER G SCHULER U RENNER U EHRSAM M ZELLER KP BLANZ J STORB R DEEG HJ
Citation: G. Ehninger et al., USE OF A WATER-SOLUBLE BUSULFAN FORMULATION - PHARMACOKINETIC STUDIESIN A CANINE MODEL, Blood, 85(11), 1995, pp. 3247-3249
DETECTION AND SEPARATION OF THE ANTHRAPYRAZOLE CI-941 AND ITS METABOLITES IN SERUM AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: PROKSCH B BLANZ J ZELLER KP EHNINGER G
Citation: B. Proksch et al., DETECTION AND SEPARATION OF THE ANTHRAPYRAZOLE CI-941 AND ITS METABOLITES IN SERUM AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 658(2), 1994, pp. 349-353
PERFORMANCE OF A CELLULAR HYBRID C TDMA MOBILE RADIO SYSTEM APPLYING JOINT DETECTION AND COHERENT RECEIVER ANTENNA DIVERSITY/
Authors: BLANZ J NASSHAN M STEIL A
Citation: J. Blanz et al., PERFORMANCE OF A CELLULAR HYBRID C TDMA MOBILE RADIO SYSTEM APPLYING JOINT DETECTION AND COHERENT RECEIVER ANTENNA DIVERSITY/, IEEE journal on selected areas in communications, 12(4), 1994, pp. 568-579
BUSULFAN PHARMACOKINETICS IN BONE-MARROW TRANSPLANT PATIENTS - IS DRUG-MONITORING WARRANTED
Authors: SCHULER U SCHROER S KUHNLE A BLANZ J MEWES K KUMBIER I PROKSCH B ZELLER KP EHNINGER G
Citation: U. Schuler et al., BUSULFAN PHARMACOKINETICS IN BONE-MARROW TRANSPLANT PATIENTS - IS DRUG-MONITORING WARRANTED, Bone marrow transplantation, 14(5), 1994, pp. 759-765
SYNTHESIS AND STRUCTURAL ELUCIDATION OF BILIARY EXCRETED THIOETHER DERIVATIVES OF MITOXANTRONE
Authors: MEWES K BLANZ J FREUND S EHNINGER G ZELLER KP
Citation: K. Mewes et al., SYNTHESIS AND STRUCTURAL ELUCIDATION OF BILIARY EXCRETED THIOETHER DERIVATIVES OF MITOXANTRONE, Xenobiotica, 24(3), 1994, pp. 199-213
FORMATION OF REACTIVE INTERMEDIATES BY CYTOCHROME-P-450 MEDIATED OXIDATION OF THE ANTICANCER DRUG MITOXANTRONE
Authors: ZELLER KP MEWES K EHNINGER G BLANZ J
Citation: Kp. Zeller et al., FORMATION OF REACTIVE INTERMEDIATES BY CYTOCHROME-P-450 MEDIATED OXIDATION OF THE ANTICANCER DRUG MITOXANTRONE, Pure and applied chemistry, 66(10-11), 1994, pp. 2415-2418
DETECTION AND IDENTIFICATION OF HUMAN URINARY METABOLITES OF BIANTRAZOLE (CL-941)
Authors: BLANZ J RENNER U SCHMEER K EHNINGER G ZELLER KP
Citation: J. Blanz et al., DETECTION AND IDENTIFICATION OF HUMAN URINARY METABOLITES OF BIANTRAZOLE (CL-941), Drug metabolism and disposition, 21(5), 1993, pp. 955-961
CYTOCHROME-P-450-INDUCED CYTOTOXICITY OF MITOXANTRONE BY FORMATION OFELECTROPHILIC INTERMEDIATES
Authors: MEWES K BLANZ J EHNINGER G GEBHARDT R ZELLER KP
Citation: K. Mewes et al., CYTOCHROME-P-450-INDUCED CYTOTOXICITY OF MITOXANTRONE BY FORMATION OFELECTROPHILIC INTERMEDIATES, Cancer research, 53(21), 1993, pp. 5135-5142
Risultati: 1-10 |